UK pharma major AstraZeneca (LSE: AZN) today reported extended approvals in Europe for two of its cancer drugs: Imfinzi ...

US regenerative cell therapy specialist Neurona Therapeutics has announced the successful completion of an upsized and ...

US pharma major Eli Lilly’s brand value has surged by 108% since entering the weight loss market in 2023, according to a new ...

With two new lawsuits, Eli Lilly (NYSE: LLY) has escalated its legal campaign against the makers of unauthorized versions of ...

Australian biotech major CSL Limited (ASX: CSL) subsidiary CSL Behring today announced that it has successfully concluded ...

US generic manufacturer Padagis has received clearance to extend the shelf life of its over-the-counter naloxone nasal spray ...

Colorado-based Edgewise Therapeutics, a muscle disease-focused biopharma company, closed 23% lower after Wednesday’s trading.

North Carolina, USA-based clinical-stage gene therapy company Atsena Therapeutics has announced the successful closing of an ...

Swiss pharma giant Novartis (NOVN: VX) today announced the US Food and Drug Administration (FDA) has granted accelerated ...

Pharmaceuticals will be exempt from the tariffs on imports to the USA that were announced by US President Donald Trump ...

US clinical-stage biotech Nurix Therapeutics (Nasdaq: NRIX) announced that Sanofi (Euronext: SAN) has exclusively licensed an ...

US biotech Novavax (Nasdaq: NVAX) is still waiting on a decision from the Food and Drug Administration over full approval of its protein-based COVID-19 vaccine, despite the agency having set an April ...